Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyatt Hotels Corporation (H) vs Revvity Inc (RVTY) Price & Performance

Hyatt Hotels CorporationTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Hyatt Hotels Corporation vs Revvity Inc — how do they compare? Hyatt Hotels Corporation trades at $161.94 (market cap $15.02B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Hyatt Hotels Corporation and Revvity Inc are close in size by market cap, and Hyatt Hotels Corporation pays the higher dividend (0.38%). Which is the better fit depends on your goals — on Pluang, investors hold Hyatt Hotels Corporation for 148 Days and Revvity Inc for 12 Days on average.

HRVTY
Market Cap
$15.02B$16.98B
Volume
842,3401,456,900
Sector
Consumer CyclicalHealth
52-Week High
$202.09$157.36
52-Week Low
$135.42$82.26
Typical Hold Time
148 Days12 Days
Enterprise Value
$18.93B$19.30B
Dividend Yield
0.38%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hyatt Hotels Corporation

Hyatt Hotels Corporation (H) trades at $159.43, up 1.46% today, with a neutral technical stance and mixed fundamentals. The stock has beaten earnings estimates for three consecutive quarters, but profitability metrics remain thin with a net margin of 1.1% and elevated P/E of 196.83. Recent news highlights brand expansion and a strategic loyalty collaboration with Delta Air Lines, signaling growth initiatives amid a challenging profit environment.

The outlook balances growth potential from fee expansion and new partnerships against high valuation and earnings volatility. Risks include project delays, debt levels, and regional economic sensitivity. Analyst consensus is a Moderate Buy with a $197.77 price target, suggesting 24% upside, but investors face headwinds from margin pressure and competitive dynamics in the hospitality sector.

Revvity Inc

RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.

The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

H

No sentiment data available yet.

RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Hyatt Hotels Corporation

Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.

Read more on H →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →